Amgen
AMGN
#104
Rank
NZ$255.55 B
Marketcap
$475.42
Share price
0.59%
Change (1 day)
8.29%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$141.66 Billion

According to Amgen's latest financial reports the company's total liabilities are NZ$141.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amgen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$143.77 B48.52%
2022-12-31NZ$96.80 B21.4%
2021-12-31NZ$79.73 B7.46%
2020-12-31NZ$74.20 B-0.12%
2019-12-31NZ$74.29 B-7.57%
2018-12-31NZ$80.37 B4.34%
2017-12-31NZ$77.03 B11.75%
2016-12-31NZ$68.93 B8.8%
2015-12-31NZ$63.36 B14.84%
2014-12-31NZ$55.17 B2.98%
2013-12-31NZ$53.57 B25.08%
2012-12-31NZ$42.83 B12.03%
2011-12-31NZ$38.23 B50.95%
2010-12-31NZ$25.33 B8.47%
2009-12-31NZ$23.35 B-15.6%
2008-12-31NZ$27.66 B26.38%
2007-12-31NZ$21.89 B4.05%
2006-12-31NZ$21.04 B62.58%
2005-12-31NZ$12.94 B-2.95%
2004-12-31NZ$13.33 B28.93%
2003-12-31NZ$10.34 B-12.26%
2002-12-31NZ$11.78 B299.34%
2001-12-31NZ$2.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$215.69 B 52.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$129.96 B-8.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$101.43 B-28.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$61.41 B-56.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.31 B-85.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$233.42 B 64.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$183.76 B 29.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.60 B-95.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$104.15 B-26.48%๐Ÿ‡บ๐Ÿ‡ธ USA